Meta’s $2B move targets reliable AI work, with Manus using KV cache tuning to cut costs while helping teams finish complex ...
Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in ...
Company to host conference call and webcast at 8:30 a.m. ET on Thursday, January 8, 2026WATERTOWN, Mass., Jan. 06, 2026 ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
The upgrades to the B-52's engines and numerous other systems are so dramatic the Air Force plans to redesignate the Cold War ...
The firm pioneers a construction methodology which involves assembling facilities from pre-fabricated modules made at a ...
EST GH Research (GHRS) to seek FDA alignment on Phase 3 program replicating Phase 2b design Published first on TheFly – the ultimate source ...
InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...
China is reviewing the acquisition over export controls, raising fears of an AI ‘brain drain’ and tougher rules on offshore ...
The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durable benefits in ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for ...